OPTIMA CAPITAL LLC

Position in ABBV — AbbVie Inc.

CIK 2070972 PORTLAND, OR

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$413,947

+$60,092 QoQ

Shares Held

1,645

+1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#3,347

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

OPTIMA CAPITAL LLC holds $1,870,365 across 6 Drug Manufacturers - General names. ABBV ranks #2 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,666	$423,113
2	ABBV	AbbVie Inc. This page	1,645	$413,947
3	LLY	ELI LILLY & Co	286	$343,036
4	MRK	Merck & Co., Inc.	2,017	$259,184
5	GILD	Gilead Sciences, Inc.	1,708	$215,788
6	PFE	Pfizer Inc	8,941	$215,297

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$413,947	1,645	+1.1%	Shares	Sole	2026-07-24
2026-03-31	$353,855	1,627	+0.3%	Shares	Sole	2026-05-05
2025-12-31	$370,610	1,622	-7.7%	Shares	Sole	2026-01-23
2025-09-30	$407,047	1,758	+1.2%	Shares	Sole	2025-10-27
2025-06-30	$322,606	1,738	+0.1%	Shares	Sole	2025-07-15
2025-03-31	$363,935	1,737	0.0%	Shares	Sole	2025-06-13
2024-12-31	$308,664	1,737	—	Shares	Sole	2025-06-13
No filing history on record for this holder in this stock.